
Eli Lilly
LEI FRDRIPF3EKNDJ2CQJL29, SWIFT LLYCUS33XXX
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Profile
|
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company products are sold in countries around the world. Eli Lilly products include neuroscience, endocrine, anti-infectives, cardiovascular agents, oncology, and animal health products.
|
General information
-
Organization nameEli Lilly & Company
-
Organization statusOperating organization
-
AddressLilly Corporation Centre, Indianapolis, USA, 46285
-
Site
-
IR Site
News
-
Have $1,000? This Beaten-Down Biotech Has 4 Phase 3 Obesity Trials Underway.18/11/2026
-
Prediction: $10,000 Equally Split Between Eli Lilly and Novo Nordisk Will Be Worth This Much by the End of 202716/11/2026
-
Mapping the Market: Eli Lilly shares ready to rally again13/11/2026
-
More Good News for Eli Lilly Sends the Stock Even Higher12/11/2026
-
Nvidia CEO Jensen Huang Says AI's 'Most Profound Impact' Will Be in Life Sciences -- and Eli Lilly Is Already Building on It12/11/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Stocks
General information
-
Organization nameEli Lilly & Company
-
Organization statusOperating organization
-
AddressLilly Corporation Centre, Indianapolis, USA, 46285
-
Site
-
IR Site
Codes
-
LEIFRDRIPF3EKNDJ2CQJL29
-
SWIFTLLYCUS33XXX
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
ICB4,500 Health Care
-
NACE*** ***
-
NAICS*** ***
-
CIK0000059478
-
EIN35-0470950










